Indian Railways freight loading up record 15% in 2021-22 to 1,418 MT

The ministry of railways has raised the loading target to 1,475 MT and freight revenue target to Rs 1.65 lakh crore for 2022-23

Moneycontrol News

April 01, 2022 / 18:15 IST

(Representative image)

The Indian Railways' total freight loading rose 15 percent year-on-year to 1,418.10 million tonne (MT) in 2021-22, the ministry of railways said on April 1.

The transporter earned Rs 1.43 lakh crore of gross freight revenue in 2021-22, which was 15.7 percent higher than 2020-21.

The ministry has raised the target for loading to 1,475 MT in 2022-23, while also increasing the revenue target to Rs 1.65 lakh crore.

“The incremental loading of 185 MT with 15 percent growth is the best ever growth in both absolute and percentage terms. The previous best incremental growth in percentage terms was achieved in the year 1981-82 with 12.9 percent growth. The previous best incremental loading in absolute terms was 66.1 MT achieved more than a decade ago in the year 2005-06,” the ministry said.

The rise in freight loading seen in 2021-22 was mainly on the back of sustained efforts made by the railways to improve the ease of doing business as well as improve the service delivery at competitive prices, the ministry said.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show